SK Biopharm, Q1 Operating Profit Turns Positive at 75.9 Billion KRW... Sales Reach 140 Billion KRW
[Asia Economy Reporter Gong Byung-sun] SK Biopharm announced on the 12th that it recorded an operating profit of 75.9 billion KRW in the first quarter of this year, turning to a profit.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Why This Bonus Grade?" Civil Servant Who Assaulted HR Employee... Court Rules Demotion Is Justified
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Sales reached 140 billion KRW, an increase of 3464.06% compared to the same period last year. Net profit for the period was 128.9 billion KRW, also turning to a profit.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
